Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

NK Receptor

  • Bin Xu
  • Mesfin Gewe
  • Kathryn Finton
  • Roland K. Strong
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_421

Synonyms

Historical Background

Natural Killer (NK) cells are a major component of the innate immune system, providing surveillance against infected or transformed cells without the requirement of prior host sensitization. NK cells were first discovered by their cytotoxic potency against tumor cells (Kiessling et al. 1975), and their importance was demonstrated early on in herpes viral infections, usually mild or localized, which become severe and life-threatening in NK-deficient patients. NK cell effector functions are governed by the balance of potentially opposing signals from a diverse array of both activating and inhibitory receptors on the cell surface that are not rearranged from germ-line receptor segments, unlike B and T cell receptors (BCRs, TCRs) on lymphocytes. While NK cells are now well characterized in terms of their...

This is a preview of subscription content, log in to check access.

References

  1. Biassoni R. Human natural killer receptors, co-receptors, and their ligands. In: Current protocols in immunology, vol. 84. New York: Wiley; 2009. p. 14.10.1–40.Google Scholar
  2. Billadeau DD, Upshaw JL, Schoon RA, Dick CJ, Leibson PJ. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat Immunol. 2003;4:557–64.CrossRefPubMedGoogle Scholar
  3. Boyington JC, Motyka SA, Schuck P, Brook AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature. 2000;405:537–43.CrossRefPubMedGoogle Scholar
  4. Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in human. J Exp Med. 2009;206:1495–503.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Bryceson YT, Long EO. Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol. 2008;20:344–52.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Fan QR, Long EO, Wiley DC. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol. 2001;2:452–60.CrossRefPubMedGoogle Scholar
  7. Gonzalez S, Groh V, Spies T. Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol. 2006;298:121–38.PubMedCentralPubMedGoogle Scholar
  8. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002;419:734–8.CrossRefPubMedGoogle Scholar
  9. Kaiser BK, Yim D, Chow IT, Gonzalez S, Dai Z, Mann HH, et al. Disulfide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature. 2007;447:482–6.CrossRefPubMedGoogle Scholar
  10. Kaiser BK, Pizarro JC, Kerns J, Strong RK. Structural basis of NKG2A/CD94 recognition of HLA-E. Proc Natl Acad Sci U S A. 2008;105:6696–701.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature. 1992;358:66–70.CrossRefPubMedGoogle Scholar
  12. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature. 1986;319:675–8.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Kiessling R, Klein E, Wigzell H. “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975;5:112–7.CrossRefPubMedGoogle Scholar
  14. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225–74.PubMedCrossRefGoogle Scholar
  15. Lopez-Soto A, Folgueras AR, Seto E, Gonzalez S. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. Oncogene. 2009;28:2370–82.CrossRefPubMedGoogle Scholar
  16. MacFarlane AW, Campbell KS. Signal transduction in natural killer cells. Curr Top Microbiol Immunol. 2006;298:23–57.PubMedGoogle Scholar
  17. Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med. 2008;205:725–35.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A. 2006;103:16412–7.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M. Host immune system gene targeting by a viral miRNA. Science. 2007;317:376–81.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Strong RK, McFarland BJ. NKG2D and related immunoreceptors. Adv Protein Chem. 2004;68:281–312.CrossRefPubMedGoogle Scholar
  21. Tormo J, Natarajan K, Natarajan K, Margulies DH, Mariuzza RA. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature. 1999;402:623–31.CrossRefPubMedGoogle Scholar
  22. Veillette A. Immune regulation by SLAM family receptors and SAP-related adaptors. Nat Rev Immunol. 2006;6:56–66.CrossRefPubMedGoogle Scholar
  23. Velikovsky CA, Deng L, Chlewicki LK, Fernandez MM, Kumar V, Mariuzza RA. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family. Immunity. 2007;27:572–84.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod’homme V, Aicheler R, et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol. 2008;41:206–12.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Willcox BE, Thomas LM, Bjorkman PJ. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol. 2003;4(9):913.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Bin Xu
    • 1
  • Mesfin Gewe
    • 1
  • Kathryn Finton
    • 1
  • Roland K. Strong
    • 1
  1. 1.Division of Basic SciencesFred Hutchinson Cancer Research CenterSeattleUSA